A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy

Figure 3

Graph showing vitreous clear-up time of early and late recurrent vitreous hemorrhage in participants with or without conbercept pretreatment. Subgroup pairwise analysis showed significant differences between IVC group and control group in early recurrent VH clear-up time (), but no statistical differences in late recurrent VH clear-up time between the two groups (). VH: vitreous hemorrhage; IVC: intravitreal conbercept.